We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Medivation, Inc. (MM) | NASDAQ:MDVN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 81.44 | 81.06 | 81.50 | 0 | 01:00:00 |
From May 2019 to May 2024
SAN FRANCISCO, CA--(Marketwired - Apr 24, 2014) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss first quarter 2014 financial results and provide a general business update on May 8, 2014 at 4:30 p.m. Eastern Time. A press release for the first quarter of 2014 will be released after markets close on May 8, 2014.
Interested parties may listen to the live teleconference by calling 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals may access the live audio webcast by visiting: http://investors.medivation.com/events.cfm.
About Medivation Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.
Contacts: Anne Bowdidge Sr. Director, Investor Relations (650) 218-6900
1 Year Medivation, Inc. (MM) Chart |
1 Month Medivation, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
